1. Peng K, Chen G, Liu C (2018) Association between smoking and glycemic control in diabetic patients: Results from the Risk Evaluation of cAncers in Chinese diabeTic Individuals: A lONgitudinal (REACTION) study. J Diabetes10: 408-18.
2. Rock CL, Flatt SW, Pakiz B, (2014) Weight loss, glycemic control, and cardiovascular disease risk factors in response to differential diet composition in a weight loss program in type 2 diabetes: a randomized controlled trial. Diabetes Care. 37: 1573-80.
3. Leiter LA, Berard L, Bowering CK (2013) Type 2 diabetes mellitus management in Canada: is it improving? Can J Diabetes 37: 82-9.
4. Edelman SV, Polonsky WH (2017) Type 2 Diabetes in the Real World: The Elusive Nature of Glycemic Control. Diabetes Care 40:1425-32.
5. Lee PH, Fu H, Lai TC, Chiang CY, Chan CC, (2016) Glycemic Control and the Risk of Tuberculosis: A Cohort Study. PLoS Med 13: e1002072.
6. Aronson R, Orzech N, Ye C, Goldenberg R, Brown V (2016) Specialist-led diabetes registries and predictors of poor glycemic control in type 2 diabetes: Insights into the functionally refractory patient from the LMC Diabetes Registry database. J Diabetes 8: 76-85.
7. Shan S, Gu L, Lou Q (2017) Evaluation of glycemic control in patients with type 2 diabetes mellitus in Chinese communities: a cross-sectional study. Clin Exp Med 17: 79-84.
8. Sigal RJ, Kenny GP, Boule NG (2007) Effects of aerobic training, resistance training, or both on glycemic control in type 2 diabetes: a randomized trial. Ann Intern Med 147: 357-69.
9. Heald AH, Livingston M, Malipatil N (2018) Improving type 2 diabetes mellitus glycaemic outcomes is possible without spending more on medication: Lessons from the UK National Diabetes Audit. Diabetes Obes Metab 20: 185-94.
10. Mayberry LS, Osborn CY (2012) Family support, medication adherence, and glycemic control among adults with type 2 diabetes. Diabetes Care 35: 1239-45.
11. Alberti KG, Zimmet PZ (1998) Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabet Med 15: 539-53.
12. Lu M, Safren SA, Skolnik PR (2008) Optimal recall period and response task for self-reported HIV medication adherence. AIDS Behav 12: 86-94.
13. Gonzalez JS, Schneider HE, Wexler DJ (2013) Validity of medication adherence self-reports in adults with type 2 diabetes. Diabetes Care 36: 831-7.
14. Fan M, Lyu J, He P (2014) [Chinese guidelines for data processing and analysis concerning the International Physical Activity Questionnaire]. Zhonghua Liu Xing Bing Xue Za Zhi 35: 961-4.
15. American Diabetes (2015) A (6) Glycemic targets. Diabetes Care 38: S33-40.
16. Cho NH, Shaw JE, Karuranga S (2018) IDF Diabetes Atlas: Global estimates of diabetes prevalence for 2017 and projections for 2045. Diabetes Res Clin Pract 138: 271-81.
17. Adua E, Roberts P, Sakyi SA (2017) Profiling of cardio-metabolic risk factors and medication utilisation among Type II diabetes patients in Ghana: a prospective cohort study. Clin Transl Med 6: 32.
18. Kizilgul M, Ozcelik O, Beysel S (2017) Screening for celiac disease in poorly controlled type 2 diabetes mellitus: worth it or not? BMC Endocr Disord 17: 62.
19. Saligram S, Williams EJ, Masding MG (2012) Raised liver enzymes in newly diagnosed Type 2 diabetes are associated with weight and lipids, but not glycaemic control. Indian J Endocrinol Metab 16: 1012-4.
20. Al-Jameil N, Khan FA, Arjumand S, Khan MF, Tabassum H (2014) Associated liver enzymes with hyperlipidemic profile in type 2 diabetes patients. Int J Clin Exp Pathol 7: 4345-9.
21. Nwosu BU, Stavre ZG, Maranda L, Cullen K, Lee MM (2012) Hepatic dysfunction is associated with vitamin D deficiency and poor glycemic control in diabetes mellitus. J Pediatr Endocrinol Metab 25: 181-6.
22. Gimeno-Orna JA, Verdes-Sanz G, Borau-Maorad L (2016) Baseline ALT levels as a marker of glycemic response to treatment with GLP-1 receptor agonists. Endocrinol Nutr 63: 164-70.
23. Salmela PI, Sotaniemi EA, Niemi M, Maentausta O (1984) Liver function tests in diabetic patients. Diabetes Care 7: 248-54.
24. Meltzer AA, Everhart JE (1997) Association between diabetes and elevated serum alanine aminotransferase activity among Mexican Americans. Am J Epidemiol 146: 565-71.
25. Benoit SR, Fleming R, Philis-Tsimikas A, Ji M (2005) Predictors of glycemic control among patients with Type 2 diabetes: a longitudinal study. BMC Public Health 5: 36.
26. Noureddine H, Nakhoul N, Galal A, Soubra L, Saleh M (2014) Level of A1C control and its predictors among Lebanese type 2 diabetic patients. Ther Adv Endocrinol Metab 5: 43-52.
27. Willey CJ, Andrade SE, Cohen J, Fuller JC, Gurwitz JH (2006) Polypharmacy with oral antidiabetic agents: an indicator of poor glycemic control. Am J Manag Care 12: 435-40.
28. Zhu HT, Yu M, Hu H, He QF, Pan J, Hu RY (2019) Factors associated with glycemic control in community-dwelling elderly individuals with type 2 diabetes mellitus in Zhejiang, China: a cross-sectional study. BMC Endocr Disord 19: 57.
29. Yefet E, Schwartz N, Sliman B, Ishay A, Nachum Z (2019) Good glycemic control of gestational diabetes mellitus is associated with the attenuation of future maternal cardiovascular risk: a retrospective cohort study. Cardiovasc Diabetol 18: 75.
30. Brands MW, Hopkins TE (1996) Poor glycemic control induces hypertension in diabetes mellitus. Hypertension 27: 735-9.
31. Wang Z, Chen Z, Zhang L (2018) Status of Hypertension in China: Results From the China Hypertension Survey, 2012-2015. Circulation 137: 2344-56.
32. Shamshirgaran SM, Mamaghanian A, Aliasgarzadeh A, Aiminisani N, Iranparvar-Alamdari M, et al. (2017) Age differences in diabetes-related complications and glycemic control. BMC Endocr Disord 17: 25.
33. Huri HZ, Ling DY, Ahmad WA (2015) Association between glycemic control and antidiabetic drugs in type 2 diabetes mellitus patients with cardiovascular complications. Drug Des Devel Ther 9: 4735-49.
34. Bahtiyar G, Gutterman D, Lebovitz H (2016) Heart Failure: a Major Cardiovascular Complication of Diabetes Mellitus. Curr Diab Rep 16: 116.
35. Tsujimoto T, Kajio H (2018) Benefits of Intensive Blood Pressure Treatment in Patients With Type 2 Diabetes Mellitus Receiving Standard but Not Intensive Glycemic Control. Hypertension 72: 323-30.